Orleans Capital Management Corp LA Trims Holdings in Zoetis Inc. (NYSE:ZTS)

Orleans Capital Management Corp LA lessened its position in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 43.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 4,316 shares of the company's stock after selling 3,270 shares during the quarter. Orleans Capital Management Corp LA's holdings in Zoetis were worth $752,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of ZTS. Vanguard Group Inc. grew its position in Zoetis by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 41,366,877 shares of the company's stock valued at $6,739,905,000 after buying an additional 120,158 shares during the last quarter. State Street Corp raised its position in shares of Zoetis by 0.5% in the third quarter. State Street Corp now owns 19,779,344 shares of the company's stock valued at $3,864,488,000 after buying an additional 95,856 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Zoetis by 1.8% during the fourth quarter. Geode Capital Management LLC now owns 10,617,897 shares of the company's stock worth $1,726,075,000 after purchasing an additional 190,137 shares during the last quarter. Polen Capital Management LLC grew its holdings in Zoetis by 17.5% in the 4th quarter. Polen Capital Management LLC now owns 7,483,194 shares of the company's stock valued at $1,219,237,000 after buying an additional 1,116,541 shares during the period. Finally, Wellington Management Group LLP increased its position in Zoetis by 78.5% during the fourth quarter. Wellington Management Group LLP now owns 6,958,543 shares of the company's stock worth $1,133,755,000 after purchasing an additional 3,059,255 shares during the last quarter. Hedge funds and other institutional investors own 92.80% of the company's stock.

Remove Ads

Analyst Ratings Changes

Several brokerages have issued reports on ZTS. Stifel Nicolaus lowered their price objective on shares of Zoetis from $210.00 to $180.00 and set a "buy" rating for the company in a research report on Tuesday, January 7th. StockNews.com upgraded shares of Zoetis from a "hold" rating to a "buy" rating in a research note on Friday, March 7th. Piper Sandler lifted their price objective on shares of Zoetis from $200.00 to $205.00 and gave the company an "overweight" rating in a research report on Thursday, February 27th. UBS Group started coverage on Zoetis in a research report on Monday, December 9th. They set a "neutral" rating and a $196.00 price target for the company. Finally, Morgan Stanley dropped their target price on Zoetis from $243.00 to $238.00 and set an "overweight" rating on the stock in a report on Friday, February 14th. One research analyst has rated the stock with a hold rating, ten have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, Zoetis currently has an average rating of "Buy" and an average target price of $215.90.

Zoetis Trading Down 1.8 %

Shares of Zoetis stock traded down $2.70 on Monday, reaching $149.03. 4,263,169 shares of the company's stock were exchanged, compared to its average volume of 2,601,967. The company has a market capitalization of $66.73 billion, a P/E ratio of 27.24, a price-to-earnings-growth ratio of 2.78 and a beta of 0.92. Zoetis Inc. has a 52 week low of $144.07 and a 52 week high of $200.33. The firm's 50-day moving average is $165.71 and its two-hundred day moving average is $173.26. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.08 and a current ratio of 1.75.

Zoetis (NYSE:ZTS - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.40 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.03. The business had revenue of $2.32 billion for the quarter, compared to analysts' expectations of $2.30 billion. Zoetis had a return on equity of 53.82% and a net margin of 26.86%. Sell-side analysts predict that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 3rd. Shareholders of record on Monday, April 21st will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.34%. The ex-dividend date is Monday, April 21st. Zoetis's dividend payout ratio (DPR) is currently 36.56%.

Insider Buying and Selling at Zoetis

In other Zoetis news, Director Willie M. Reed sold 1,210 shares of Zoetis stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $166.14, for a total value of $201,029.40. Following the completion of the transaction, the director now directly owns 11,245 shares of the company's stock, valued at approximately $1,868,244.30. The trade was a 9.71 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Roxanne Lagano sold 326 shares of Zoetis stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $171.18, for a total transaction of $55,804.68. Following the completion of the sale, the executive vice president now directly owns 16,107 shares of the company's stock, valued at approximately $2,757,196.26. This trade represents a 1.98 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,862 shares of company stock worth $312,254 over the last ninety days. Insiders own 0.16% of the company's stock.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.